CD20 as a Target for Therapeutic Type I and II Monoclonal Antibodies

被引：173

作者：

Beers, Stephen A. ^{[1
]}

Chan, Claude H. T. ^{[1
]}

French, Ruth R. ^{[1
]}

Cragg, Mark S. ^{[1
]}

Glennie, Martin J. ^{[1
]}

机构：

[1] Univ Southampton, Sch Med, Gen Hosp, Tenovus Lab,Canc Sci Div, Southampton SO16 6YD, Hants, England

来源：

SEMINARS IN HEMATOLOGY | 2010年 / 47卷 / 02期

基金：

英国医学研究理事会;

关键词：

CELL ANTIGEN RECEPTOR; MHC CLASS-II; SURFACE ANTIGEN; LYMPHOMA-CELLS; B-LYMPHOCYTES; RITUXIMAB; ACTIVATION; REDISTRIBUTION; MECHANISMS; EXPRESSION;

D O I：

10.1053/j.seminhematol.2010.01.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The last decade has seen the monoclonal antibody (mAb), rituximab, transform clinical management of many non-Hodgkin lymphomas and more recently provide new opportunities for controlling autoimmune conditions, such as rheumatoid arthritis. Although not yet fully determined, the explanation for this success appears to lie with the inherent properties of its target, CD20, which allow rituximab to recruit potent cytotoxic effectors with unusual efficiency. In this review we detail the properties of CD20 that make it such an effective therapeutic target and describe how different mAbs change the membrane distribution and internalization of CD20 and have distinct modes of cytotoxic activity. Semin Hematol 47:107-114. (C) 2010 Published by Elsevier Inc.

引用

页码：107 / 114

页数：8

共 60 条

[41] Colocalization of the B cell receptor and CD20 followed by activation-dependent dissociation in distinct lipid rafts [J].

Petrie, RJ ;

Deans, JP .

JOURNAL OF IMMUNOLOGY, 2002, 169 (06) :2886-2891

[42] CD20 homo-oligomers physically associate with the B cell antigen receptor - Dissociation upon receptor engagement and recruitment of phosphoproteins and calmodulin-binding proteins [J].

Polyak, Maria J. ;

Li, Haidong ;

Shariat, Neda ;

Deans, Julie P. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (27) :18545-18552

[43] A cholesterol-dependent CD20 epitope detected by the FMC7 antibody [J].

Polyak, MJ ;

Ayer, LM ;

Szczepek, AJ ;

Deans, JP .

LEUKEMIA, 2003, 17 (07) :1384-1389

[44] Alanine-170 and proline-172 are critical determinants for extracellular CD20 epitopes; heterogeneity in the fine specificity of CD20 monoclonal antibodies is defined by additional requirements imposed by both amino acid sequence and quaternary structure [J].

Polyak, MJ ;

Deans, JP .

BLOOD, 2002, 99 (09) :3256-3262

[45]

Polyak MJ, 1998, J IMMUNOL, V161, P3242

[46]

PRESS OW, 1987, BLOOD, V69, P584

[47] A Polymorphism in the Complement Component C1qA Correlates with Prolonged Response Following Rituximab Therapy of Follicular Lymphoma [J].

Racila, Emilian ;

Link, Brian K. ;

Weng, Wen-Kai ;

Witzig, Thomas E. ;

Ansell, Stephen ;

Maurer, Matthew J. ;

Huang, Jian ;

Dahle, Christopher ;

Halwani, Ahmad ;

Levy, Ronald ;

Weiner, George J. .

CLINICAL CANCER RESEARCH, 2008, 14 (20) :6697-6703

[48]

STASHENKO P, 1980, J IMMUNOL, V125, P1678

[49]

Szollosi J, 1996, J IMMUNOL, V157, P2939

[50] CD20 - A REGULATOR OF CELL-CYCLE PROGRESSION OF B-LYMPHOCYTES [J].

TEDDER, TE ;

ENGEL, P .

IMMUNOLOGY TODAY, 1994, 15 (09) :450-454

← 1 2 3 4 5 6 →